These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 13039339)

  • 1. [Experimental studies on the effect of elkosin on the H2S splitting by Escherichia coli bacteria].
    TANNERT S
    Z Gesamte Inn Med; 1952 Nov; 7(22):1042-6. PubMed ID: 13039339
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapeutic activity of 6-sulfanilamido-2,4-dimethylpyrimidine (elkosin).
    EISMAN PC; GEFTIC SG; LIGENZOWSKI F; MAYER RL
    Proc Soc Exp Biol Med; 1952 Jul; 80(3):493-5. PubMed ID: 14949095
    [No Abstract]   [Full Text] [Related]  

  • 3. An evaluation of elkosin, gantrisin and sulfacetamide in standardized infections in mice.
    WHITE HJ; WADSWORTH BC; REDIN GS; GENTILE AJ
    Antibiot Chemother (Northfield); 1952 Dec; 2(12):659-77. PubMed ID: 24542157
    [No Abstract]   [Full Text] [Related]  

  • 4. IN VITRO SENSITIVITY OF ESCHERICHIA COLI TO SULFONAMIDES.
    GLANTZ PJ
    Cornell Vet; 1965 Jan; 55():9-18. PubMed ID: 14284453
    [No Abstract]   [Full Text] [Related]  

  • 5. Advent of elkosin.
    BANERJI B
    Ind Med Gaz; 1950 Jul; 85(7):298-302. PubMed ID: 14794175
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of elkosin on the infected mouse, on the development and oxidation processes of bacteria in the glass in comparison with cibazole].
    FREI W; JEZIERSKI A
    Schweiz Z Pathol Bakteriol; 1946; 9(4):277-90. PubMed ID: 20281315
    [No Abstract]   [Full Text] [Related]  

  • 7. [Frequency of complications in sulfadimethylpyrimidine (elkosin) therapy in 443 cases].
    HARSLØF E; PETERSEN H
    Ugeskr Laeger; 1950 May; 112(19):669-71. PubMed ID: 15443090
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effects of sulfonamides and antibiotics on destruction products of coli bacteria].
    WILDE W
    Med Monatsschr; 1952 May; 6(5):320. PubMed ID: 14956661
    [No Abstract]   [Full Text] [Related]  

  • 9. [New sulfonamide preparations (elkosin, aristamid, mefenal)].
    GRUNKE W
    Ther Ggw; 1951 Nov; 90(11):411-5. PubMed ID: 14893235
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the cross resistance of bacteria to sulfonamides. II. The behavior of bacteria towards sulfonamides substituted in N1 with heterocyclic six-- membered rings].
    Höhne C; Patsch R
    Zentralbl Bakteriol Orig; 1967 Jan; 202(2):220-6. PubMed ID: 4970771
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative oral toxicity of 6-sulphonamido-2,4-dimethylpyrimidine (elkosin) and of various sulphonamide combinations.
    TRIPOD J
    Arch Int Pharmacodyn Ther; 1953 Jul; 94(3):338-45. PubMed ID: 13093052
    [No Abstract]   [Full Text] [Related]  

  • 12. Sulfadimetine (elkosin) in ophthalmology.
    HURWITZ P
    Am J Ophthalmol; 1953 Nov; 36(11):1621-3. PubMed ID: 13104575
    [No Abstract]   [Full Text] [Related]  

  • 13. Elkosin in the management of urinary tract infections.
    BOGASH M; ELLIS H; MURPHY JJ
    J Am Med Assoc; 1956 Aug; 161(16):1564-5. PubMed ID: 13345625
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary tract infections: experience with elkosin.
    PHILLIPS CA; LLOYD FA
    J Urol; 1954 Dec; 72(6):1247-54. PubMed ID: 13212949
    [No Abstract]   [Full Text] [Related]  

  • 15. [Local chemotherapy in diffuse and local appendical peritonitis, with special attention to elkosin].
    HENNICKE W; KERSTNER G
    Z Arztl Fortbild (Jena); 1956 Feb; 50(3):129-33. PubMed ID: 13325572
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy with a new sulfonamide triple mixture; sulfadiazine, sulfamerazine, elkosin.
    LEHR D; TERRANOVA R; BLUMENFELD S; GOLDFARB ML
    Postgrad Med; 1953 Mar; 13(3):231-38. PubMed ID: 13037579
    [No Abstract]   [Full Text] [Related]  

  • 17. [Respiratory activity, reproductive activity and phosphorus content of bacteria from culture media containing sulfonamides].
    KAYSER F; POUTEAU-THOUVENOT M
    Bull Soc Chim Biol (Paris); 1951; 33(11-12):1718-25. PubMed ID: 14935690
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental and clinical experiences with elkosin, 6-sulfanilamido-2-4-dimethylpyrimidine].
    PREUSS HG
    Munch Med Wochenschr; 1950 Nov; 92(31-32):1301-5. PubMed ID: 14796609
    [No Abstract]   [Full Text] [Related]  

  • 19. Inactivity of pteroylglutamic acid and leucovorin in overcoming sulfonamide growth inhibition of Escherichia coli.
    ALIMCHANDANI HR; SREENIVASAN A
    J Bacteriol; 1957 Aug; 74(2):171-4. PubMed ID: 13475216
    [No Abstract]   [Full Text] [Related]  

  • 20. The growth promoting and antisulfonamide activity of pteroylglutamic acid and related compounds for Escherichia coli and Aerobacter aerogenes.
    HAVAS HF; McGEADY AP
    J Bacteriol; 1953 Nov; 66(5):531-7. PubMed ID: 13108851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.